◼ Archived
Business
🔮 Newsylist predicts: fades by tomorrow medium confidence — graded ✓ correct
‘It is what it is’: Merck exec unruffled by ‘unfortunate’ leak of ESMO cancer vaccine data
3sources
3articles
1velocity
+0%since first seen
22d agofirst detected
Text:
🤖 AI Dossier
How fast it spread
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Sources (3)
-
-
-
Moderna Melanoma Therapy Cuts Recurrence Risk 42% in Phase 3 Trial Yahoo Finance · 22d ago broke it first
📊 AUDIENCE & LONGEVITY PULSE
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
People, places & organizations
Related trends
▲ Peaking
Business
Cruise buffet controversy puts passengers who cut the line in the hot seat
▲ Peaking
Business
Michael Burry sees 2 chip winners in Nvidia’s shake-up
▲ Peaking
Business
Samsung, SK hynix, and Micron Fail to Get DRAM Antitrust Suit Dismissed
▲ Peaking
Business
New York hit with lawsuit over state's new social media warning label law
🔥 Breakout ↑ Rising
Business
Japan's economy unexpectedly contracts in third-quarter as elevated energy costs bite
▲ Peaking
Business